Item 4 of 60 (back to results) previous next cabergoline An N-acylurea that is (8R)-ergoline-8-carboxamide in which the hydrogen attached to the piperidine nitrogen (position 6) is substituted by an allyl group and the hydrogens attached to the carboxamide nitrogen are substituted by a 3-(dimethylamino)propyl group and an N-ethylcarbamoyl group. A dopamine D2 receptor agonist, cabergoline is used in the management of Parkinson's disease and of disorders associated with hyperprolactinaemia.

Current search: 03. Biological Effects of Specific Chemicals: pharmacological uses [CHEBI:52210] × 05. Industrial Uses: pharmaceutical [CHEBI:52217] > drug [CHEBI:23888] > antineoplastic agent [CHEBI:35610] × Select any link to see items in a related category. more general categories    information about this item 03. Biological Effects of Specific Chemicals  03. Biological Effects of Specific Chemicals  pharmacological uses [CHEBI:52210] (736)   neurotransmitter agent [CHEBI:35942] (471)   dopaminergic agent [CHEBI:48560] (99)   dopamine agonist [CHEBI:51065] (26)   cabergoline [CHEBI:3286] (1) 05. Industrial Uses  05. Industrial Uses  pharmaceutical [CHEBI:52217] (1978)   drug [CHEBI:23888] (1930)   antineoplastic agent [CHEBI:35610] (760)   cabergoline [CHEBI:3286] (1)  antidyskinesia agent [CHEBI:66956] (43)   antiparkinson drug [CHEBI:48407] (41)   cabergoline [CHEBI:3286] (1) 08. Chemical Category  08. Chemical Category  main group molecular entity [CHEBI:33579] (25650)   p-block molecular entity [CHEBI:33675] (25343)   pnictogen molecular entity [CHEBI:33302] (10027)   nitrogen molecular entity [CHEBI:51143] (7930)   amide [CHEBI:32988] (1863)   primary amide [CHEBI:33256] (1586)   ureas [CHEBI:47857] (101)   N-acylurea [CHEBI:74266] (18)   cabergoline [CHEBI:3286] (1) ChEBI Compound Accession Identifier:   [CHEBI:3286] ChEBI Compound Description:   An N-acylurea that is (8R)-ergoline-8-carboxamide in which the hydrogen attached to the piperidine nitrogen (position 6) is substituted by an allyl group and the hydrogens attached to the carboxamide nitrogen are substituted by a 3-(dimethylamino)propyl group and an N-ethylcarbamoyl group. A dopamine D2 receptor agonist, cabergoline is used in the management of Parkinson's disease and of disorders associated with hyperprolactinaemia. ChEBI Compound Identification Number:   3286 ChEBI InChI Value:   InChI=1S/C26H37N5O2/c1-5-11-30-17-19(25(32)31(26(33)27-6-2)13-8-12-29(3)4)14-21-20-9-7-10-22-24(20)18(16-28-22)15-23(21)30/h5,7,9-10,16,19,21,23,28H,1,6,8,11-15,17H2,2-4H3,(H,27,33)/t19-,21-,23-/m1/s1 ChEBI InChIKey Value:   KORNTPPJEAJQIU-KJXAQDMKSA-N ChEBI Compound Name:   cabergoline ChEBI SMILES Value:   [H][C@@]12Cc3c[nH]c4cccc(c34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC ChEBI Substance ID:   92740959 ChEBI URL:   ChEBI:3286 ChemSpider ID:   49452 Ontomatica Chemical Accession Key (OnChAKey):   KORNTPPJEAJQIU_KJXAQDMKSA_N_000_000000 PubChem Compound ID:   54746